''

Other testsBack

Maternal Blood Y-DNA Test (MBY)

Fetal DNA is fragmented when placental materials (particles) are being pushed into the maternal blood circulation. The fetal DNA fragments circulate freely in the maternal blood which refers to the cell-free fetal DNA (ccfDNA). Therefore, by taking the mother's blood samples, fetal DNA material can be detected. With advanced technology in Science, Maternal Blood Y-DNA Test is able to distinguish fetal DNA from maternal blood in women of 7 gestational weeks or above. From the results, we are able to detect any presence of Y-DNA in maternal blood.

 

Fragile X Carrier Screening (MFX)

Fragile X syndrome is one of the main causes of autism, a common genetic disease. Fragile X syndrome or its related diseases occurs due to lack of FMR1 genome expression. FMR1 absence affects mental development and causes many other problems.

Both Fragile X Carrier Screening & Maternal Blood Y-DNA test are included in the package. By using Polymerase Chain Reaction (PCR), this screening test examines the expansions of CGG tri-nucleotide repeats in Fragile Mental Retardation-1 (FMR1) gene on X-chromosome. Maternal Blood Y-DNA test is included in this test in order to provide more information about the state of fragile X syndrome.

Please click here to know more: http://www.angliatech.com/clients2/diagcor/site/zh-hant/pregnancy_guide/detail/5/

 

Maternal Blood Y-DNA Test (MBY) + Y-chromosome DNA Exclusion (MBE)

Maternal blood Y-DNA test (MBY) must be done before conducting Y-chromosome DNA exclusion (MBE). If the MBY test results indicate that there is a detectable amount of Y-DNA in the sample submitted, then the expected mother can proceed to take the MBE test. The MBE test aims to analyze and compare the DNA markers, which are found by the fetal DNA in the maternal blood sample, with the alleged father's blood sample in order to find out whether their parent-child relation is excluded or not.

 

Non-Invasive Prenatal Parentage Testing (DDC)

Newer DNA technologies take advantage of the fact that there is free fetal DNA circulating in the mother's bloodstream. The test is able to separate the fetal DNA from the maternal blood, while assuming the father can provide his blood or mouth cell samples for analysis.

 
 
 
$50 Gift Certificate

Maternal Blood Y-DNA Test (MBY)

Fetal DNA is fragmented when placental materials (particles) are being pushed into the maternal blood circulation. The fetal DNA fragments circulate freely in the maternal blood which refers to the cell-free fetal DNA (ccfDNA). Therefore, by taking the mother's blood samples, fetal DNA material can be detected. With advanced technology in Science, Maternal Blood Y-DNA Test is able to distinguish fetal DNA from maternal blood in women of 7 gestational weeks or above. From the results, we are able to detect any presence of Y-DNA in maternal blood.

 

Fragile X Carrier Screening (MFX)

Fragile X syndrome is one of the main causes of autism, a common genetic disease. Fragile X syndrome or its related diseases occurs due to lack of FMR1 genome expression. FMR1 absence affects mental development and causes many other problems.

Both Fragile X Carrier Screening & Maternal Blood Y-DNA test are included in the package. By using Polymerase Chain Reaction (PCR), this screening test examines the expansions of CGG tri-nucleotide repeats in Fragile Mental Retardation-1 (FMR1) gene on X-chromosome. Maternal Blood Y-DNA test is included in this test in order to provide more information about the state of fragile X syndrome.

Please click here to know more: http://www.angliatech.com/clients2/diagcor/site/zh-hant/pregnancy_guide/detail/5/

 

Maternal Blood Y-DNA Test (MBY) + Y-chromosome DNA Exclusion (MBE)

Maternal blood Y-DNA test (MBY) must be done before conducting Y-chromosome DNA exclusion (MBE). If the MBY test results indicate that there is a detectable amount of Y-DNA in the sample submitted, then the expected mother can proceed to take the MBE test. The MBE test aims to analyze and compare the DNA markers, which are found by the fetal DNA in the maternal blood sample, with the alleged father's blood sample in order to find out whether their parent-child relation is excluded or not.

 

Non-Invasive Prenatal Parentage Testing (DDC)

Newer DNA technologies take advantage of the fact that there is free fetal DNA circulating in the mother's bloodstream. The test is able to separate the fetal DNA from the maternal blood, while assuming the father can provide his blood or mouth cell samples for analysis.



Enquiry Now